Apollomics

Apollomics is a global biotechnology company dedicated to the discovery and development of oncology therapies. They are committed to harnessing the immune system and targeting specific molecular pathways to inhibit cancer. They are headquartered in Foster City, CA, USA, with additional facilities in China and Australia. Their approach combines sound scientific rationale with a focus on precision therapies, combination therapies, and pan-cancer treatments. They have a diverse portfolio of innovative drug candidates at various stages of development, including two late-stage clinical trials.

Apollomics emphasizes a collaborative approach, partnering with other biotechnology companies in the East and West. Their in-house research and development team has capabilities in drug discovery and development and they have strategically developed a global intellectual property portfolio. Their mission is to develop and commercialize treatment solutions that improve the lives of patients living with cancer.

Apollomics offers competitive personal time off days and a health club subsidy. They also offer medical, dental, and vision insurance, as well as a 401K plan that includes a company match. The company's website does not mention flexible work arrangements, remote work options, or work from home opportunities.

Apollomics provides comprehensive employee benefits, including medical, dental, and vision insurance, competitive personal time off days, a health club subsidy, and a 401K plan with a company match. These benefits are designed to support the well-being of employees and promote a healthy work-life balance.

Apollomics is a biotechnology company committed to eradicating cancer by developing and commercializing innovative oncology therapies. They focus on harnessing the body's immune system and targeting specific molecular pathways to inhibit cancer growth, with a particular emphasis on combination therapies that work synergistically with other treatment options.

Apollomics promotes a culture that values innovation, execution, integrity, collaboration and respect. They believe in developing novel oncology medicines and effective combination therapies to improve the lives of those living with life-threatening malignancies. They strive to achieve their goals by combining individual performance with teamwork and a spirit of partnership, while acknowledging individual worth, establishing trust and fostering tolerance to develop increased productivity, recognition and cooperation.

Apollomics is committed to building a diverse and inclusive workplace where all employees feel valued, respected, and empowered to contribute their unique perspectives. They value a culture of innovation, execution, integrity, collaboration, and respect, fostering a supportive environment where individuals can thrive and contribute to their mission of eradicating cancer.